The new strategy shares themes with health secretary Robert F. Kennedy Jr.’s Make America Health Again agenda. He has called ...

A deal with Lilly and Novo would be significant for the administration’s push for lower drug prices for Americans.

We’re also continuing to track the fallout from all the recent FDA controversies.

A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts ...

In this edition of STAT's Health Tech newsletter: the latest on GLP-1 microdosing, AI for medical coding and more.

Azalea's first drug candidate is a CAR-T therapy for cancer and autoimmune conditions that turns immune cells into cancer ...

Fewer pre-teens and adolescents are vaping nicotine these days than in previous years. But a study published yesterday in ...

The findings are similar to an analysis STAT conducted, and raise questions about why UnitedHealth pays its doctors more.

Sobriety didn’t restore the old version of me; it allowed me to build a new one from the driftwood of the past,” ...

In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement ...

It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...

Sarepta Therapeutics delivered a disastrous third-quarter earnings performance. A long-delayed confirmatory clinical trial of ...